Level B· Emerging clinical evidence with positive signals
Stromal Vascular Fraction Therapy for Knee Osteoarthritis: A Systematic Review
Goncharov E.N., Koval O.A., Bezuglov E.N., Montemurro N.
Screened 172 articles and included 22; most reported safety and improved clinical outcomes, but designs varied widely.
Level B· Emerging clinical evidence with positive signalsEvidence level of this study
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
- Study type
- Systematic Review
- Journal
- Medicina (Kaunas) (2023)
- Country
- Russia / Italy
- Sample size
- —
- Follow-up
- Varied across included studies
- PMID
- 38138193
- DOI
- 10.3390/medicina59122090
What was studied
Collated SVF studies for knee osteoarthritis published between 2017 and 2023.
Methods
- • Searched PubMed, Medline and Scopus for SVF, knee osteoarthritis and regenerative medicine.
Key findings
- • Most studies reported improved clinical outcomes and minimal adverse events.
- • Reviewers stressed that differences in sample size and design require cautious interpretation.
Limitations
- • No quantitative meta-analysis was performed.
- • Most included studies lacked rigorous control groups.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • Limited follow-up cannot indicate long-term outcomes.
Clinical interpretation
A useful overview of knee SVF literature, but not a substitute for RCT evidence.
Evidence level: Emerging clinical evidence with positive signals